drugset / Trial / NCT00113750
Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen
RandomizedParallel-groupSingle-blindTreatment
Summary
Tree MATA (modified pollen allergen tyrosine adsorbate) has been developed to provide pre-seasonal specific immunotherapy for patients with hypersensitivity to tree (birch, alder, and hazel) pollen. Different doses of Tree MATA will be administered and immunological changes following this treatment will be assessed.
Timeline
- Start
- 2005-07
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tree MATA MPL | Other / unclassified | — | Subcutaneous |